Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2011
10/26/2011EP2021475B1 High-affinity antagonists of elr-cxc chemokines
10/26/2011EP1994051B1 Gene encoding trehalose-6-phosphate phosphatase and use thereof
10/26/2011EP1945657B1 Tlr3 glycosylation site muteins and methods of use
10/26/2011EP1910410B1 Tuberculosis antigen detection assays and vaccines
10/26/2011EP1902067B1 Alleles of the opca gene from coryneform bacteria
10/26/2011EP1851317B1 Alteration of tobacco alkaloid content through modification of specific cytochrome p450 genes
10/26/2011EP1742964B1 Peptide capable of altering tubulin polymerization and use thereof for inhibiting cell proliferation
10/26/2011EP1723170B1 A canine vaccine for protection against ehrlichiosis
10/26/2011EP1692158B1 Vegf binding and supported peptides for treating skin diseases
10/26/2011EP1684719B1 Alpha 1-antitrypsin compositions and treatment methods using such compositions
10/26/2011EP1660678B1 Mutant adeno-associated virus virions and methods of use thereof
10/26/2011EP1587526B1 Mntf peptides and compositions and methods of use
10/26/2011EP1541685B1 Factor participating in transcriptional regulation
10/26/2011EP1469310B1 Diagnostic for scleroderma
10/26/2011EP1463822B1 Method for the production of cell lines with latent immunodeficiency virus
10/26/2011EP1427837B1 Modular transfection systems based on nucleoprotein filaments
10/26/2011EP1409748B1 Recombinant Adenoviruses comprising simian adenovirus proteins and uses thereof.
10/26/2011EP1060247B2 Ox-40 receptor binding agent for use in methods for enhancing tumour antigen-specific immune response
10/26/2011EP0956359B1 High fidelity detection of nucleic acid differences by ligase detection reaction
10/26/2011EP0787191B2 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens
10/26/2011CN1678624B Benzoate- and anthranilate-inducible promoters
10/26/2011CN102227444A Vaccins of plasmodium, antigens, compositions and process
10/26/2011CN102227443A Therapeutic ribonucleases
10/26/2011CN102227215A Surface active proteins as excipients in solid pharmaceutical formulations
10/26/2011CN102226186A Activated Bax gene for treating malignant tumor by taking adenovirus as carrier
10/26/2011CN102225967A Method of preparing pilose antler polypeptide with pure natural, high activity and high purity
10/26/2011CN102225964A Self-assembling peptide amphiphiles and related methods for growth factor delivery
10/26/2011CN102225963A Method for reducing acetonitrile residue in polypeptide medicament
10/26/2011CN101503469B Method for extracting soy protein, oligosaccharide and isoflavone from soybean whey by two-stage two-segment film
10/26/2011CN101289666B Method for preparing recombination porcine alpha-type interferon
10/26/2011CN101228271B Method for bacillus coli to high effectively excrine representing lysostaphin
10/26/2011CN101168562B CBP C end protein, monoclonal antibody thereof, preparation and use of the same
10/25/2011US8044266 AXMI-008, a delta-endotoxin gene and methods for its use
10/25/2011US8044263 Cytokinin oxidase promoter from maize
10/25/2011US8044262 Generation of plants with improved drought tolerance
10/25/2011US8044259 Determining the capability of a test compound to affect solid tumor stem cells
10/25/2011US8044193 Short interfering RNAs targeted to T-LAK cell-originated protein kinase (TOPK) polynucleotide
10/25/2011US8044191 Using expression vector comprising nucleotide sequences coding elongation factor regulatory sequences as high efficiency gene transfer tool
10/25/2011US8044189 Bacillus anthracis protective antigen nucleic acid sequences
10/25/2011US8044187 having an increased activity over the wild-type human glycoprotein; reproduction disorders; cancer such as thyroid carcinoma
10/25/2011US8044183 Process for the production of immunogenic compositions
10/25/2011US8044182 Adiponectin and uses thereof
10/25/2011US8044177 Water-soluble keratin derivative and use thereof
10/25/2011US8044175 Peptides that specifically bind HGF receptor (CMET) and uses thereof
10/25/2011US8044174 Thrombopoietic compounds
10/25/2011US8044025 Urocortin proteins and uses thereof
10/25/2011US8044021 Sustained release of apo A-I mimetic peptides and methods of treatment
10/25/2011US8044018 Reagents and methods for smooth muscle therapies
10/25/2011US8044017 Ion exchange chromatography; gradient wash; resolution; remove impurities
10/25/2011US8043851 DNA encoding a neoculin acidic subunit of curculin
10/25/2011US8043850 Fluorescent protein and gene encoding the same
10/25/2011US8043831 Therapeutic agents comprising pro-apoptotic proteins
10/25/2011US8043806 Method of diagnosing an RTK-hyperfunction induced disorder
10/25/2011US8043627 Osteogenic composite matrix, method for the production thereof and implant and scaffold for tissue engineering provided with a coating formed by said osteogenic composite matrix
10/25/2011US8043623 Immunogenic peptides for the treatment of prostate and breast cancer
10/25/2011US8043615 Methods of antagonizing LDCAM and CRTAM
10/25/2011US8043608 Methods of using Fc-cytokine fusion proteins
10/25/2011CA2712304C Recombinant chimeric proteins and methods of use thereof
10/25/2011CA2448329C Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
10/25/2011CA2437983C Transporters comprising spaced arginine moieties
10/25/2011CA2437866C Novel clock gene bmal2
10/25/2011CA2415923C Novel tumor antigen useful in diagnosis and therapy of bladder, ovary, lung and kidney cancers
10/25/2011CA2409007C Novel laccase enzyme and the gene encoding the enzyme
10/25/2011CA2399865C Novel scavenger receptor
10/25/2011CA2395499C Chlamydia antigens and corresponding dna fragments and uses thereof
10/25/2011CA2372709C Vector for integration of heterologous sequences into poxviral genomes
10/22/2011CA2700466A1 Modification of intrinsically disordered sequences for the preparation of vaccines
10/20/2011WO2011130666A2 Plants with altered cell wall biosynthesis and methods of use
10/20/2011WO2011130618A2 Compositions and methods for producing glycosylated human pdx-1 protein and methods of use therefore
10/20/2011WO2011130533A1 Engineered plant cysteine proteases and their uses
10/20/2011WO2011130354A1 Fibronectin based scaffold domain proteins that bind pcsk9
10/20/2011WO2011130340A1 Methods and compositions for the diagnosis and treatment of cancer resistant to anaplastic lymphoma kinase (alk) kinase inhibitors
10/20/2011WO2011130145A1 Banana lectins and uses thereof
10/20/2011WO2011129756A1 Methods and combination
10/20/2011WO2011129468A1 Hexon isolated from simian adenovirus serotype 19, hypervariable region thereof and chimeric adenovirus using the same
10/20/2011WO2011128892A2 Modified forms of pneumococcal surface immunogenic protein b (psipb)
10/20/2011WO2011128863A1 Antigenic structure and uses thereof for screening trypanosomiases in humans and animals
10/20/2011WO2011128720A1 Trans-activator of transcription protein
10/20/2011WO2011128561A1 Robo1-fc fusion protein and use thereof for treating tumours
10/20/2011WO2011128445A1 Inhibitors of the accumulation of sprd transcripts in s. aureus
10/20/2011WO2011128429A1 Antagonists for the prevention or treatment of inflammatory bowel disease, and more particularly of crohn's disease
10/20/2011WO2011128415A1 Cross-protecting vaccine for porcine reproductive and respiratory syndrome virus
10/20/2011WO2011128247A1 N-terminal hpv e7 fusion proteins
10/20/2011WO2011127971A1 Polyacetylenic compounds with anti-fungal activity derived from the bacterium collimonas and methods for the preparation and identification thereof
10/20/2011WO2011127802A1 Polypeptides having glucoamylase activity and polynucleotides encoding same
10/20/2011WO2011127744A1 Protein ipa1 related to plant architecture, its coding genes and uses
10/20/2011WO2011127580A1 Compositions and methods for brain delivery of analgesic peptides
10/20/2011WO2011106696A3 Compositions and methods for the production of l-homoalanine
10/20/2011WO2011093932A3 Design of fibrinogen and fibrinogen derived products with reduced bacterial binding by using modified sequences of fibrinogen chains
10/20/2011WO2011090272A9 OsMPT GENE MODIFYING PLANT ARCHITECTURE (PLANT SHAPE) AND INCREASING YIELD, AND USE THEREOF
10/20/2011WO2011084685A3 Saposin-a derived peptides and uses thereof
10/20/2011WO2011056954A3 Haemophilus parasuis polypeptides and methods of use
10/20/2011WO2010076361A8 Inclusion bodies, bacterial cells and compositions containing them and uses thereof
10/20/2011US20110258742 Stress Tolerant Transgenic Crop Plants
10/20/2011US20110258741 Wuschel(wus) gene homologs
10/20/2011US20110258740 Genes, proteins and vectors for increasing tolerance of plants and microbes to abiotic stresses and the use thereof
10/20/2011US20110258738 Tor-interacting proteins (tips) and genes therefor
10/20/2011US20110258731 Soybean Cultivar 93454905
10/20/2011US20110258730 Soybean Cultivar 97450705
10/20/2011US20110258729 Soybean Cultivar 99401805